These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34679181)
1. Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study. van Geest FS; Groeneweg S; van den Akker ELT; Bacos I; Barca D; van den Berg SAA; Bertini E; Brunner D; Brunetti-Pierri N; Cappa M; Cappuccio G; Chatterjee K; Chesover AD; Christian P; Coutant R; Craiu D; Crock P; Dewey C; Dica A; Dimitri P; Dubey R; Enderli A; Fairchild J; Gallichan J; Garibaldi LR; George B; Hackenberg A; Heinrich B; Huynh T; Kłosowska A; Lawson-Yuen A; Linder-Lucht M; Lyons G; Monti Lora F; Moran C; Müller KE; Paone L; Paul PG; Polak M; Porta F; Reinauer C; de Rijke YB; Seckold R; Menevşe TS; Simm P; Simon A; Spada M; Stoupa A; Szeifert L; Tonduti D; van Toor H; Turan S; Vanderniet J; de Waart M; van der Wal R; van der Walt A; van Wermeskerken AM; Wierzba J; Zibordi F; Zung A; Peeters RP; Visser WE J Clin Endocrinol Metab; 2022 Feb; 107(3):e1136-e1147. PubMed ID: 34679181 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. Groeneweg S; Peeters RP; Moran C; Stoupa A; Auriol F; Tonduti D; Dica A; Paone L; Rozenkova K; Malikova J; van der Walt A; de Coo IFM; McGowan A; Lyons G; Aarsen FK; Barca D; van Beynum IM; van der Knoop MM; Jansen J; Manshande M; Lunsing RJ; Nowak S; den Uil CA; Zillikens MC; Visser FE; Vrijmoeth P; de Wit MCY; Wolf NI; Zandstra A; Ambegaonkar G; Singh Y; de Rijke YB; Medici M; Bertini ES; Depoorter S; Lebl J; Cappa M; De Meirleir L; Krude H; Craiu D; Zibordi F; Oliver Petit I; Polak M; Chatterjee K; Visser TJ; Visser WE Lancet Diabetes Endocrinol; 2019 Sep; 7(9):695-706. PubMed ID: 31377265 [TBL] [Abstract][Full Text] [Related]
3. Impact of Early Intervention with Triiodothyroacetic Acid on Peripheral and Neurodevelopmental Findings in a Boy with MCT8 Deficiency. Ünsal Y; Hayran G J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):116-122. PubMed ID: 38054413 [TBL] [Abstract][Full Text] [Related]
4. Measurement of Reverse Triiodothyronine Level and the Triiodothyronine to Reverse Triiodothyronine Ratio in Dried Blood Spot Samples at Birth May Facilitate Early Detection of Monocarboxylate Transporter 8 Deficiency. Iwayama H; Kakita H; Iwasa M; Adachi S; Takano K; Kikuchi M; Fujisawa Y; Osaka H; Yamada Y; Okumura A; Hirani K; Weiss RE; Refetoff S Thyroid; 2021 Sep; 31(9):1316-1321. PubMed ID: 34049438 [No Abstract] [Full Text] [Related]
5. Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by Refetoff S; Pappa T; Williams MK; Matheus MG; Liao XH; Hansen K; Nicol L; Pierce M; Blasco PA; Wiebers Jensen M; Bernal J; Weiss RE; Dumitrescu AM; LaFranchi S Thyroid; 2021 May; 31(5):713-720. PubMed ID: 32746752 [No Abstract] [Full Text] [Related]
6. Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target. Shaji D Curr Drug Discov Technol; 2021; 18(1):105-112. PubMed ID: 31774046 [TBL] [Abstract][Full Text] [Related]
7. Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. Verge CF; Konrad D; Cohen M; Di Cosmo C; Dumitrescu AM; Marcinkowski T; Hameed S; Hamilton J; Weiss RE; Refetoff S J Clin Endocrinol Metab; 2012 Dec; 97(12):4515-23. PubMed ID: 22993035 [TBL] [Abstract][Full Text] [Related]
8. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients. Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548 [TBL] [Abstract][Full Text] [Related]
9. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment. Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621 [TBL] [Abstract][Full Text] [Related]
10. [MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature]. López-Marín L; Martín-Belinchón M; Gutiérrez-Solana LG; Morte-Molina B; Duat-Rodríguez A; Bernal J Rev Neurol; 2013 Jun; 56(12):615-22. PubMed ID: 23744248 [TBL] [Abstract][Full Text] [Related]
11. TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice. Reinwald JR; Weber-Fahr W; Cosa-Linan A; Becker R; Sack M; Falfan-Melgoza C; Gass N; Braun U; Clemm von Hohenberg C; Chen J; Mayerl S; Muente TF; Heuer H; Sartorius A Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555189 [TBL] [Abstract][Full Text] [Related]
12. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels. Boccone L; Dessì V; Meloni A; Loudianos G Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639 [TBL] [Abstract][Full Text] [Related]